NASDAQ: GILD
Gilead Sciences Inc Stock Ownership - Who owns Gilead Sciences?

Insider buying vs selling

Have Gilead Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Wettan Keeley M. CainEVP2026-11-063,399$164.11
$557.81kSell
Daniel Patrick OdayCEO;Chair2026-11-059,810$175.17
$1.72MSell
Daniel Patrick OdayCEO;Chair2026-11-059,810$72.34
$709.66kBuy
Daniel Patrick OdayCEO;Chair2026-11-04102,619$175.16
$17.98MSell
Daniel Patrick OdayCEO;Chair2026-11-04102,619$72.34
$7.42MBuy
Daniel Patrick OdayCEO;Chair2026-11-022,000$171.06
$342.13kSell
Daniel Patrick OdayCEO;Chair2026-11-021,904$169.27
$322.30kSell
Daniel Patrick OdayCEO;Chair2026-11-021,700$168.10
$285.77kSell
Daniel Patrick OdayCEO;Chair2026-11-021,600$167.40
$267.84kSell
Daniel Patrick OdayCEO;Chair2026-11-027,796$170.35
$1.33MSell

1 of 13

GILD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GILD insiders and whales buy or sell their stock.

GILD Shareholders

What type of owners hold Gilead Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
John C. Martin0.29%3,619,142$607.83MInsider
Norbert W. Bischofberger0.19%2,393,196$401.94MInsider
Gordon Earle Moore0.15%1,917,337$322.02MInsider
John F. Milligan0.14%1,797,816$301.94MInsider
Etienne Davignon0.07%838,652$140.85MInsider
Daniel Patrick Oday0.04%551,683$92.66MInsider
James M. Denny0.02%308,058$51.74MInsider
Gayle E. Wilson0.02%229,052$38.47MInsider
Robin L. Washington0.02%226,989$38.12MInsider
Curated Wealth Partners LLC0.02%216,192$36.31MInstitution

1 of 3

GILD vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GILD0.09%1.11%Net SellingNet Selling
PFE0.07%0.27%Net Buying
AMGN0.08%1.01%Net Selling
AZN0.05%0.00%Net SellingNet Buying
BMY0.08%0.37%Net SellingNet Selling

Gilead Sciences Stock Ownership FAQ

Who owns Gilead Sciences?

Gilead Sciences (NASDAQ: GILD) is owned by 0.09% institutional shareholders, 1.11% Gilead Sciences insiders, and 98.80% retail investors. John C. Martin is the largest individual Gilead Sciences shareholder, owning 3.62M shares representing 0.29% of the company. John C. Martin's Gilead Sciences shares are currently valued at $607.83M.

If you're new to stock investing, here's how to buy Gilead Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.